. Are surrogate markers adequate to assess cardiovascular disease drugs?. JAMA. 1999 Aug 25;282(8):790-5. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

News

  1. Chicago: Studies Probe Diminishing Placebo Decline, Part 2